Literature DB >> 27663789

Linking the seroresponse to infection to within-host heterogeneity in antibody production.

P F M Teunis1, J C H van Eijkeren2, W F de Graaf3, A Bonačić Marinović4, M E E Kretzschmar5.   

Abstract

A recently published model for the serum antibody response to infection appeared well suited for use in statistical analyses of longitudinal serological data. The published model assumed exponential decay with fixed rates for pathogen and serum antibody kinetics, ignoring any within-host heterogeneity in the seroresponse. A bi-exponential model shows that there is rapid initial decay followed by a prolonged period of persistent low serum antibody concentrations. We propose a small modification of the decay model that greatly increases its flexibility by allowing for non-exponential antibody decay. The modified model produces power functions that may be interpreted as a mixture of exponential decay curves, with a mixing distribution representing the relative contribution of many centres of antibody production to the serum antibody concentration. Fitting the power function decay model to observed longitudinal data for pertussis shows improved goodness of fit compared to the exponential decay model, with estimates for the shape parameter (r=2.2; 95% CI (1.7-2.8)) that differ from exponential shape (r=1). The power function decay model predicts more persistent antibody concentrations in the long term (symptomatic threshold reached >30 years after infection) which, when used in biomarker studies, will lead to lower estimates of seroconversion rates compared to exponential antibody decay.
Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Parameter estimation; Pertussis; Serology; Waning immunity; Within-host model

Mesh:

Substances:

Year:  2016        PMID: 27663789     DOI: 10.1016/j.epidem.2016.04.001

Source DB:  PubMed          Journal:  Epidemics        ISSN: 1878-0067            Impact factor:   4.396


  18 in total

1.  Kinetics of Meningococcal Serogroup C-Specific Functional Antibody Levels Up to 15 Years after a Single Immunization with a Meningococcal Serogroup C Conjugate Vaccine during Adolescence.

Authors:  Susanne P Stoof; Mariëtte B van Ravenhorst; Debbie M van Rooijen; Richarda M de Voer; Fiona R M van der Klis; Greet J Boland; Elisabeth A M Sanders; Guy A M Berbers; Peter F Teunis
Journal:  Clin Vaccine Immunol       Date:  2017-02-06

2.  Humoral Responses Against SARS-CoV-2 and Variants of Concern After mRNA Vaccines in Patients With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia.

Authors:  Andres Chang; Akil Akhtar; Susanne L Linderman; Lilin Lai; Victor M Orellana-Noia; Rajesh Valanparambil; Hasan Ahmed; Veronika I Zarnitsyna; Ashley A McCook-Veal; Jeffrey M Switchenko; Jean L Koff; Kristie A Blum; Amy A Ayers; Colin B O'Leary; Michael C Churnetski; Shahana Sulaiman; Melissa Kives; Preston Sheng; Carl W Davis; Ajay K Nooka; Rustom Antia; Madhav V Dhodapkar; Mehul S Suthar; Jonathon B Cohen; Rafi Ahmed
Journal:  J Clin Oncol       Date:  2022-04-18       Impact factor: 50.717

3.  Models and analyses to understand threats to polio eradication.

Authors:  James S Koopman
Journal:  BMC Med       Date:  2017-12-22       Impact factor: 8.775

4.  Robust Humoral and Cellular Immune Responses to Pertussis in Adults After a First Acellular Booster Vaccination.

Authors:  Saskia van der Lee; Debbie M van Rooijen; Mary-Lène de Zeeuw-Brouwer; Marjan J M Bogaard; Pieter G M van Gageldonk; Axel Bonacic Marinovic; Elisabeth A M Sanders; Guy A M Berbers; Anne-Marie Buisman
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

5.  Assessing the stability of polio eradication after the withdrawal of oral polio vaccine.

Authors:  Michael Famulare; Christian Selinger; Kevin A McCarthy; Philip A Eckhoff; Guillaume Chabot-Couture
Journal:  PLoS Biol       Date:  2018-04-27       Impact factor: 8.029

6.  Heterogeneity and longevity of antibody memory to viruses and vaccines.

Authors:  Alice Antia; Hasan Ahmed; Andreas Handel; Nichole E Carlson; Ian J Amanna; Rustom Antia; Mark Slifka
Journal:  PLoS Biol       Date:  2018-08-10       Impact factor: 8.029

7.  Linking longitudinal and cross-sectional biomarker data to understand host-pathogen dynamics: Leptospira in California sea lions (Zalophus californianus) as a case study.

Authors:  K C Prager; Michael G Buhnerkempe; Denise J Greig; Anthony J Orr; Eric D Jensen; Forrest Gomez; Renee L Galloway; Qingzhong Wu; Frances M D Gulland; James O Lloyd-Smith
Journal:  PLoS Negl Trop Dis       Date:  2020-06-29

8.  Novel Intervention in the Aging Population: A Primary Meningococcal Vaccine Inducing Protective IgM Responses in Middle-Aged Adults.

Authors:  Marieke van der Heiden; Annemieke M H Boots; Axel A Bonacic Marinovic; Lia G H de Rond; Marjan van Maurik; Irina Tcherniaeva; Guy A M Berbers; Anne-Marie Buisman
Journal:  Front Immunol       Date:  2017-07-19       Impact factor: 7.561

9.  Seroepidemiologic Study Designs for Determining SARS-COV-2 Transmission and Immunity.

Authors:  Hannah Clapham; James Hay; Isobel Routledge; Saki Takahashi; Marc Choisy; Derek Cummings; Bryan Grenfell; C Jessica E Metcalf; Michael Mina; Isabel Rodriguez Barraquer; Henrik Salje; Clarence C Tam
Journal:  Emerg Infect Dis       Date:  2020-06-16       Impact factor: 6.883

10.  Waning and boosting: on the dynamics of immune status.

Authors:  O Diekmann; W F de Graaf; M E E Kretzschmar; P F M Teunis
Journal:  J Math Biol       Date:  2018-05-15       Impact factor: 2.259

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.